Quick and Cost-Effective Molecular Profiling of Difficult NSCLC Samples

Wednesday, November 20, 2024 | 2:00 - 2:50 PM PST
Room #114-115, Level 1

Add to Calendar ICS File Add to Your Calendar

Are you facing challenges with QNS rates in your NSCLC samples? Mutation profiling doesn’t have to be complex—or costly. Join us for this AMP 2024 workshop featuring Dr. Ravindra Kolhe, Professor and Chair of Pathology at Georgia Cancer Center and Dr. Darren Davis, Senior Vice President at Precision for Medicine.

Why Attend? Learn how to:

  • Ensure accurate data, even with challenging samples
  • Simplify your molecular profiling workflows
  • Reduce costs and turnaround times

An AMP Annual Meeting badge or Corporate Workshop Day badge is needed to attend the workshop.

PRESENTED BY:

Dr Ravindra Kolhe

Ravindra Kolhe, MD, PhD, FCAP, Professor and Chair of Pathology, Medical College of Georgia 

Dr. Kolhe is a Professor and Leon Henri Charbonnier Endowed Chair in Pathology at Augusta University. He is the inaugural Associate Dean for translation research at the Medical College of Georgia. He also serves as the Associate Cancer Center Director for Genomics at the Georgia Cancer Center. Currently, he leads an NCI-designated translational pathology laboratory for MATCH testing focused on comprehensive genomic testing in oncology. 
Dr Darren Davis

Darren W. Davis, PhD, Senior Vice President, Precision For Medicine

Dr. Davis is a visionary leader with decades of distinguished biotechnology and clinical translational biomarker research experience. He founded ApoCell in 2004 and later was instrumental in developing and commercializing the ApoStream rare-cell liquid biopsy technology. Globally recognized cancer researcher and the author of more than 100 peer-reviewed publications. Dr. Davis is dedicated and committed to improving the lives of patients with debilitating diseases.

Sign Up for the Replay

Register to get the replay and watch it on your time!

Connect with Us
icon_img
Exciting News in PGx! We are thrilled to announce the launch of an advanced solution in pharmacogenetic analysis—VeriDose Core v2.0, with updated gene targets aligned with AMP Tier 1 and Tier 2 recommendations...
More
icon_img
Agena Bioscience is proud to collaborate with our distribution partner, EXSA SRL, and its CEO, Ezequiel Boezio, in our mission to broaden the use of our cost-effective, targeted molecular analysis portfolio...
More